drugset / Trial / NCT07522736
Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims to compare the duration of analgesia (as the primary outcome) and adverse effects (as the secondary outcome) after intrathecal administration of dexmedetomidine with hyperbaric bupivacaine to patients undergoing knee orthopedic surgery.
Timeline
- Start
- 2025-03-01
- Primary completion
- 2026-08-30
- Completion
- 2026-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 4 ug | Intrathecal |
| Subject | Dexmedetomidine | Other / unclassified | 8 ug | Intrathecal |
| Subject | Dexmedetomidine | Other / unclassified | 12 ug | Intrathecal |
Indications
No indication recorded.